Uptake of PrEP and condom and sexual risk behavior among MSM during the ANRS IPERGAY trial

References

• Baeten, J. M., Donnell, D., Ndase, P., Mugo, N. R., Campbell, J. D., Wangisi, J., … Partners PrEP Study Team. (2012). Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. The New England Journal of Medicine, 367(5), 399–410. Retrieved from http://doi.org/10.1056/NEJMoa1108524 doi: 10.1056/NEJMoa1108524
   PubMed Web of Science ®Google Scholar
• Blashill, A. J., Ehlinger, P. P., Mayer, K. H., & Safren, S. A. (2015). Optimizing adherence to preexposure and postexposure prophylaxis: The need for an integrated biobehavioral approach. Clinical Infectious Diseases, 60(Suppl. 3), S187–S190. Retrieved from http://doi.org/10.1093/cid/civ111 doi: 10.1093/cid/civ111
   Google Scholar
• Carlo Hojilla, J., Koester, K. A., Cohen, S. E., Buchbinder, S., Ladzekpo, D., Matheson, T., & Liu, A. Y. (2015). Sexual behavior, risk compensation, and HIV prevention strategies among participants in the San Francisco PrEP demonstration project: A qualitative analysis of counseling notes. AIDS and Behavior. Retrieved from http://doi.org/10.1007/s10461-015-1055-5
   PubMed Web of Science ®Google Scholar
• Cassell, M. M., Halperin, D. T., Shelton, J. D., & Stanton, D. (2006). HIV and risk behaviour: Risk compensation: The Achilles’ heel of innovations in HIV prevention? BMJ: British Medical Journal, 332(7541), 605–607. doi: 10.1136/bmj.332.7541.605
   Web of Science ®Google Scholar
• Cazein, F., Pillonel, J., Le Strat, Y., Pinget, R., Le Vu, S., Brunet, S., … Lot, F. (2015). Découvertes de séropositivité VIH et de SIDA, France, 2003–2013 [New HIV and AIDS diagnoses, France, 2003–2013]. Bulletin Épidémiologique Hebdomadaire, 9–10, 152–161.
   Google Scholar
• Choopanya, K., Martin, M., Suntharasamai, P., Sangkum, U., Mock, P. A., Leethochawalit, M., … Bangkok Tenofovir Study Group. (2013). Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): A randomised, double-blind, placebo-controlled phase 3 trial. Lancet (London, England), 381(9883), 2083–2090. Retrieved from http://doi.org/10.1016/S0140-6736(13)61127-7 doi: 10.1016/S0140-6736(13)61127-7
   PubMed Web of Science ®Google Scholar
• Cohen, M. S. (2010). HIV treatment as prevention and « The Swiss Statement »: In for a Dime, in for a Dollar? Clinical Infectious Diseases, 51(11), 1323–1324. Retrieved from http://doi.org/10.1086/656810 doi: 10.1086/656810
   PubMed Web of Science ®Google Scholar
• Cohen, M. S., Chen, Y. Q., McCauley, M., Gamble, T., Hosseinipour, M. C., Kumarasamy, N., … HPTN 052 Study Team. (2011). Prevention of HIV-1 infection with early antiretroviral therapy. The New England Journal of Medicine, 365(6), 493–505. Retrieved from http://doi.org/10.1056/NEJMoa1105243 doi: 10.1056/NEJMoa1105243
   PubMed Web of Science ®Google Scholar
• Corneli, A. L., Deese, J., Wang, M., Taylor, D., Ahmed, K., Agot, K., … FEM-PrEP Study Group. (2014). FEM-PrEP: Adherence patterns and factors associated with adherence to a daily oral study product for pre-exposure prophylaxis. Journal of Acquired Immune Deficiency Syndromes (1999), 66(3), 324–331. Retrieved from http://doi.org/10.1097/QAI.0000000000000158 doi: 10.1097/QAI.0000000000000158
   PubMed Web of Science ®Google Scholar
• Eaton, L. A., & Kalichman, S. (2007). Risk compensation in HIV prevention: Implications for vaccines, microbicides, and other biomedical HIV prevention technologies. Current HIV/AIDS Reports, 4(4), 165–172. doi: 10.1007/s11904-007-0024-7
   PubMedGoogle Scholar
• Gilmore, H. J., Liu, A., Koester, K. A., Amico, K. R., McMahan, V., Goicochea, P., … Grant, R. (2013). Participant experiences and facilitators and barriers to pill use among men who have sex with men in the iPrEx pre-exposure prophylaxis trial in San Francisco. AIDS Patient Care and STDs, 27(10), 560–566. Retrieved from http://doi.org/10.1089/apc.2013.0116 doi: 10.1089/apc.2013.0116
   PubMed Web of Science ®Google Scholar
• Grant, R. M., Anderson, P. L., McMahan, V., Liu, A., Amico, K. R., Mehrotra, M., … Glidden, D. V. (2014). Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: A cohort study. The Lancet Infectious Diseases, 14(9), 820–829. Retrieved from http://doi.org/10.1016/S1473-3099(14)70847-3 doi: 10.1016/S1473-3099(14)70847-3
   PubMed Web of Science ®Google Scholar
• Grant, R. M., Lama, J. R., Anderson, P. L., McMahan, V., Liu, A. Y., Vargas, L., … iPrEx Study Team. (2010). Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. The New England Journal of Medicine, 363(27), 2587–2599. Retrieved from http://doi.org/10.1056/NEJMoa1011205 doi: 10.1056/NEJMoa1011205
   PubMed Web of Science ®Google Scholar
• Guest, G., Shattuck, D., Johnson, L., Akumatey, B., Clarke, E. E. K., Chen, P.-L., & MacQueen, K. M. (2008). Changes in sexual risk behavior among participants in a PrEP HIV prevention trial. Sexually Transmitted Diseases, 35(12), 1002–1008.
   PubMed Web of Science ®Google Scholar
• Haberer, J. E., Baeten, J. M., Campbell, J., Wangisi, J., Katabira, E., Ronald, A., … Bangsberg, D. R. (2013). Adherence to antiretroviral prophylaxis for HIV prevention: A substudy cohort within a clinical trial of Serodiscordant couples in East Africa. PLoS Medicine, 10(9), e1001511. Retrieved from http://doi.org/10.1371/journal.pmed.1001511 doi: 10.1371/journal.pmed.1001511
   PubMed Web of Science ®Google Scholar
• Hogben, M., & Liddon, N. (2008). Disinhibition and risk compensation: Scope, definitions, and perspective. Sexually Transmitted Diseases, 35(12), 1009–1010.
   PubMed Web of Science ®Google Scholar
• Kamb, M. L., Fishbein, M., Douglas, J. M., Rhodes, F., Rogers, J., Bolan, G., … Peterman, T. A. (1998). Efficacy of risk-reduction counseling to prevent human immunodeficiency virus and sexually transmitted diseases: A randomized controlled trial. Project RESPECT Study Group. JAMA, 280(13), 1161–1167. doi: 10.1001/jama.280.13.1161
   PubMed Web of Science ®Google Scholar
• Liu, A. Y., Vittinghoff, E., Chillag, K., Mayer, K., Thompson, M., Grohskopf, L., … Buchbinder, S. P. (2013). Sexual risk behavior among HIV-uninfected men who have sex with men (MSM) participating in a tenofovir pre-exposure prophylaxis (PrEP) randomized trial in the United States. Journal of Acquired Immune Deficiency Syndromes, 64(1), 87–94. Retrieved from http://doi.org/10.1097/QAI.0b013e31828f097a
   PubMed Web of Science ®Google Scholar
• Marcus, J. L., Glidden, D. V., Mayer, K. H., Liu, A. Y., Buchbinder, S. P., Amico, K. R., … Grant, R. M. (2013). No evidence of sexual risk compensation in the iPrEx trial of daily oral HIV preexposure prophylaxis. PLoS ONE, 8(12), e81997. Retrieved from http://doi.org/10.1371/journal.pone.0081997 doi: 10.1371/journal.pone.0081997
   PubMed Web of Science ®Google Scholar
• McCormack, S., Dunn, D. T., Desai, M., Dolling, D. I., Gafos, M., Gilson, R., … Gill, O. N. (2015). Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): Effectiveness results from the pilot phase of a pragmatic open-label randomised trial. Lancet (London, England). Retrieved from http://doi.org/10.1016/S0140-673(15)00056-2
   PubMed Web of Science ®Google Scholar
• Molina, J.-M., Capitant, C., Spire, B., Pialoux, G., Cotte, L., Charreau, I., … ANRS IPERGAY Study Group. (2015). On-demand preexposure prophylaxis in men at high risk for HIV-1 infection. The New England Journal of Medicine, 373(23), 2237–2246. Retrieved from http://doi.org/10.1056/NEJMoa1506273 doi: 10.1056/NEJMoa1506273
   PubMed Web of Science ®Google Scholar
• Tangmunkongvorakul, A., Chariyalertsak, S., Amico, K. R., Saokhieo, P., Wannalak, V., Sangangamsakun, T., … Grant, R. (2012). Facilitators and barriers to medication adherence in an HIV prevention study among men who have sex with men in the iPrEx study in Chiang Mai, Thailand. AIDS Care, 25(8), 961–967. Retrieved from http://doi.org/10.180/0954011.2012.748871 doi: 10.1080/09540121.2012.748871
   PubMed Web of Science ®Google Scholar
• Thigpen, M. C., Kebaabetswe, P. M., Paxton, L. A., Smith, D. K., Rose, C. E., Segolodi, T. M., … Brooks, J. T. (2012). Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. The New England Journal of Medicine, 367(5), 423–434. Retrieved from http://doi.org/10.1056/NEJMoa1110711 doi: 10.1056/NEJMoa1110711
   PubMed Web of Science ®Google Scholar
• Underhill, K. (2013). Study designs for identifying risk compensation behavior among users of biomedical HIV prevention technologies: Balancing methodological rigor and research ethics. Social Science & Medicine, 94, 115–123. Retrieved from http://doi.org/10.1016/j.socscimed.2013.03.020 doi: 10.1016/j.socscimed.2013.03.020
   PubMed Web of Science ®Google Scholar
• Van Damme, L., Corneli, A., Ahmed, K., Agot, K., Lombaard, J., Kapiga, S., … Taylor, D. (2012). Preexposure prophylaxis for HIV infection among African women. The New England Journal of Medicine, 367(5), 411–422. Retrieved from http://doi.org/10.1056/NEJMoa1202614 doi: 10.1056/NEJMoa1202614
   PubMed Web of Science ®Google Scholar
• Volk, J. E., Marcus, J. L., Phengrasamy, T., Blechinger, D., Nguyen, D. P., Follansbee, S., & Hare, C. B. (2015). No new HIV infections with increasing use of HIV preexposure prophylaxis in a clinical practice setting. Clinical Infectious Diseases. Retrieved from http://doi.org/10.1093/cid/civ778
   Web of Science ®Google Scholar